Clinical Trials in Salt Lake City

Showing 5061-5080 of 16,694 trials

Lipoic Acid for Progressive Multiple Sclerosis (MS)

NCT03161028

The purpose of the study is to determine if lipoic acid can preserve mobility and protect the brain in progressive forms of multiple sclerosis.

Multiple Sclerosis

VA Office of Research and Development115 participantsStarted Aug 2018

Birmingham, Alabama, United States • Aurora, Colorado, United States • Washington D.C., District of Columbia, United States +8 more locations

COMPLETEDPhase 1< 1 mile

A Drug-Drug Interaction Study of Orforglipron (LY3502970) With Quinidine in Healthy Participants

NCT06704763

The purpose of this study is to determine the effect of quinidine on the levels of orforglipron in the blood stream and how long it takes the body to eliminate it, when administered orally in healthy participants. The study will last up to approximately 8 weeks including screening.

Healthy

Eli Lilly and Company27 participantsStarted Dec 2024

Salt Lake City, Utah, United States

Lipoic Acid for Progressive Multiple Sclerosis (MS)

A Drug-Drug Interaction Study of Orforglipron (LY3502970) With Quinidine in Healthy Participants

Find Trials by Condition in Salt Lake City

A Phase 2 Study of IW-3300 for the Treatment of Bladder Pain in Subjects With Interstitial Cystitis/Bladder Pain Syndrome

Study to Evaluate Sodium Phenylbutyrate in Pre-symptomatic Infants With Spinal Muscular Atrophy

PROACTIVE-HF IDE Trial Heart Failure NYHA Class III

A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD

Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma

Cisplatin and Gemcitabine Hydrochloride With or Without Berzosertib in Treating Patients With Metastatic Urothelial Cancer

NAP in Combination With Docetaxel Following Obinutuzumab Pretreatment in Subjects With Checkpoint Inhibitor Pretreated Advanced or Metastatic NSCLC

Study of EYP-1901 in Patients With Diabetic Macular Edema (DME)

Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer

TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing Cancer

Cardiovascular Risk Screening and Risk Reduction in Women Vets

Improving BP Control in Diverse Populations Using BP MAP

TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)

Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria

Effect of Extraneal (Icodextrin)on Triglyceride Levels in PD Patients

EPI-7386 in Combination with Enzalutamide Compared with Enzalutamide Alone in Subjects with MCRPC

A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody in Subjects With Recurrent/Metastatic Cervical Cancer

Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS)